Lakestar recently closed a $300m fund named Resilience I focused on defence and dual-use technology, with a portfolio including Helsing, Tekever, ARX Robotics, and Isar Aerospace.
Klaus chairs Lakestar and holds board seats at Isar Aerospace, the Munich Security Conference, and SumUp. He previously chaired the NATO Innovation Fund and served on the board of Neko Health.
The Series A round was led by Album VC with participation from Karma Ventures,.406 Ventures, Atlantic Bridge, IQ Capital and Lakestar.
"AI is creating an entirely new attack surface, and organisations need a fundamentally different approach to securing it. We don’t just automate attacks. We operationalize expertise, turning the knowledge of leading AI security researchers and offensive security practitioners into the capabilities every enterprise needs to secure their AI"
The $300m Series C values the defence tech startup at $3.4bn following backing from DFJ Growth.
"This raise is testament to the incredible work of the entire Cambridge Aerospace team. The addition of these funds will allow us to continue to scale our manufacturing and our delivery to meet the pace of threats, and the needs of Allied nations,"
The funding follows the assembly of a coalition of major British institutions to co-design a domestic AI model.
"AI is the single most important technology of our generation. Enterprises are increasingly waking up to the risk of being wholly dependent on foreign providers for this technology. Vendor lock-in creates security risk, dependency risk, and cost escalation risks,"
The British Business Bank has backed the warehouse robotics provider as part of its recent Series C round.
"The UK consistently produces companies with market-leading technology, which need greater domestic backing to scale globally. The Bank is stepping up to ensure companies like Dexory have the capital they need to innovate and expand here in the UK. We are working with fund managers to create deeper pools of capital and are increasing the scale of our co-investing activity, which directly increases the size of funding rounds for high-potential UK companies."